Early use of ECMO devices to support adults with cardiogenic shock did not improve clinical outcomes

Glass laboratory flasks on light table

The immediate use of veno-arterial mechanical circulatory extracorporeal membrane oxygenation (ECMO) devices to support adults with rapidly deteriorating or severe cardiogenic shock was feasible but did not improve clinical outcomes compared to people who received early conservative therapy, according to late-breaking clinical trial results presented today at the American Heart Association’s Scientific Sessions 2022.

Rosuvastatin vastly superior to six common heart health supplements

Previous article

Children exposed to air pollution in early years more likely to develop food allergies

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News